Erdanaf 3 (Erdafitinib 3 mg) – Product Overview
BizHQ – Medicine India Export provides pharmaceutical sourcing and export enquiry services for international medicine importers, wholesalers, distributors, and healthcare suppliers.
Erdanaf 3 (Erdafitinib Tablets 3 mg) is a prescription oncology medicine manufactured by Natco Pharma, India. Erdafitinib belongs to a class of medicines known as FGFR inhibitors and is used for certain types of cancer under specialist medical supervision.
Product Details
Product Name: Erdanaf 3
Generic Name: Erdafitinib
Strength: 3 mg
Manufacturer: Natco Pharma
Dosage Form: Tablets
Packaging: 28 Tablets
Category: Oncology / Anticancer Medicine
Country of Origin: India
Erdafitinib 3 mg Uses
Erdafitinib is a targeted cancer medicine used for certain patients with advanced urothelial cancer who have specific FGFR3 genetic alterations. Treatment eligibility depends on the applicable regulatory approval and specialist assessment.
The medicine should only be used under the supervision of a qualified healthcare professional.
Erdanaf 3 Export from India – Target Countries
BizHQ welcomes pharmaceutical sourcing enquiries from licensed buyers across international markets, including:
North America: USA, Canada, Mexico
Europe: UK, Germany, France, Italy, Spain, Netherlands
Middle East: UAE, Saudi Arabia, Qatar, Kuwait, Oman, Bahrain
Asia: Singapore, Malaysia, Thailand, Philippines, Vietnam, Nepal, Bangladesh, Sri Lanka
Africa: South Africa, Nigeria, Kenya, Ghana, Uganda, Tanzania
Oceania: Australia, New Zealand
South America: Brazil, Chile, Colombia, Peru
Product availability and export eligibility depend on local medicine registration, import permits, and applicable pharmaceutical regulations.
Why Choose BizHQ – Medicine India Export?
Pharmaceutical sourcing assistance from India
International B2B medicine export enquiries
Support with product and shipping documentation
Wholesale procurement coordination
Communication with international pharmaceutical buyers
All product supply arrangements are subject to verification of availability, licensing, and regulatory compliance.
Frequently Asked Questions (FAQs)
1. What is Erdanaf 3 used for?
Erdanaf 3 contains Erdafitinib, which is used in certain patients with urothelial cancer involving specific FGFR genetic alterations.
2. Who manufactures Erdanaf 3?
The product packaging identifies Natco Pharma as the manufacturer.
3. Can I import Erdafitinib 3 mg from India?
Importation depends on your country's pharmaceutical regulations, product approval status, and required import permissions.
4. Is Erdanaf 3 available for wholesale orders?
Licensed pharmaceutical buyers can enquire about product availability, minimum order quantities, and procurement requirements.
5. Can I request Erdafitinib 3 mg export pricing?
Yes. Contact BizHQ with your required quantity, destination country, and company details to request sourcing information and a quotation, subject to availability and legal eligibility.
6. What documents are required for international medicine shipping?
Requirements may include an import license, commercial invoice, packing list, product quality documents, and destination-specific approvals.
Contact BizHQ – Medicine India Export
For Erdanaf 3 (Erdafitinib 3 mg) pharmaceutical sourcing and international wholesale enquiries, contact:
🌐 Website: https://www.medicineindiaexport.com
📧 Email: sales.medindiaexport@gmail.com
📱 WhatsApp: +91 7218129896
BizHQ – Your Partner for International Pharmaceutical Sourcing from India.
